Page last updated: 2024-08-18

pyrroles and l 731988

pyrroles has been researched along with l 731988 in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's10 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Blau, C; Espeseth, A; Felock, P; Gabryelski, L; Grobler, JA; Hazuda, DJ; Miller, MD; Schleif, W; Stillmock, K; Witmer, M; Wolfe, A1
Anthony, N; Cole, JL; Egbertson, M; Espeseth, AS; Felock, P; Grobler, J; Hamill, T; Hazuda, DJ; Melamed, JY; Witmer, M; Wolfe, A; Young, S1
Keserû, GM; Kolossváry, I1
Lee, DJ; Reinke, R; Robinson, WE1
Beale, K; King, PJ; Lee, DJ; Reinke, RA; Robinson, WE; Victoria, JG1
Johnson, AA; Marchand, C; Pommier, Y1
King, PJ; Lee, DJ; Lei, X; Mao, Y; McDougall, BR; Reinecke, MG; Reinke, RA; Robinson, WE; Victoria, J1
Grant, GH; Huang, M; Richards, WG1
Chen, JM; Chen, X; Hung, M; Jin, H; Jones, GS; Kim, CU; Qi, X; Swaminathan, S; Tsiang, M; Yu, F; Zeynalzadegan, A1
Barreca, ML; Chimirri, A; De Luca, L; Iraci, N1

Reviews

1 review(s) available for pyrroles and l 731988

ArticleYear
HIV-1 integrase inhibitors: a decade of research and two drugs in clinical trial.
    Current topics in medicinal chemistry, 2004, Volume: 4, Issue:10

    Topics: Acetoacetates; Anti-HIV Agents; Biological Factors; Caffeic Acids; Clinical Trials as Topic; Furans; HIV Integrase; HIV Integrase Inhibitors; HIV-1; Humans; Indoles; Models, Molecular; Molecular Structure; Oligonucleotides; Pyrroles; Reverse Transcriptase Inhibitors; Succinates; Tetrazoles; Triazoles

2004

Other Studies

9 other study(ies) available for pyrroles and l 731988

ArticleYear
Inhibitors of strand transfer that prevent integration and inhibit HIV-1 replication in cells.
    Science (New York, N.Y.), 2000, Jan-28, Volume: 287, Issue:5453

    Topics: Acetoacetates; Anti-HIV Agents; Catalysis; Coculture Techniques; DNA, Circular; DNA, Viral; Drug Resistance, Microbial; HIV Integrase; HIV Integrase Inhibitors; HIV Long Terminal Repeat; HIV-1; Humans; Mutation; Pyrroles; Recombinant Proteins; T-Lymphocytes; Transcription, Genetic; Tumor Cells, Cultured; Virus Integration; Virus Replication

2000
HIV-1 integrase inhibitors that compete with the target DNA substrate define a unique strand transfer conformation for integrase.
    Proceedings of the National Academy of Sciences of the United States of America, 2000, Oct-10, Volume: 97, Issue:21

    Topics: Acetoacetates; Base Sequence; Catalysis; DNA Primers; DNA, Viral; Epitopes; HIV Integrase; HIV Integrase Inhibitors; HIV-1; Pyrroles; Substrate Specificity

2000
Fully flexible low-mode docking: application to induced fit in HIV integrase.
    Journal of the American Chemical Society, 2001, Dec-19, Volume: 123, Issue:50

    Topics: Acetoacetates; Algorithms; Binding Sites; Catalytic Domain; HIV Integrase; HIV Integrase Inhibitors; Models, Molecular; Protein Conformation; Pyrroles; Thermodynamics

2001
Inhibition of human immunodeficiency virus type 1 isolates by the integrase inhibitor L-731,988, a diketo Acid.
    Antimicrobial agents and chemotherapy, 2002, Volume: 46, Issue:10

    Topics: Acetoacetates; Cell Line; HIV Integrase; HIV Integrase Inhibitors; HIV-1; Humans; Molecular Sequence Data; Pyrroles; Sequence Analysis, DNA; Virus Replication

2002
Human immunodeficiency virus type-1 integrase containing a glycine to serine mutation at position 140 is attenuated for catalysis and resistant to integrase inhibitors.
    Virology, 2003, Feb-01, Volume: 306, Issue:1

    Topics: Acetoacetates; Amino Acid Substitution; Caffeic Acids; Cell Line; Drug Resistance, Viral; HIV Integrase; HIV Integrase Inhibitors; HIV-1; Humans; Pyrroles; Reverse Transcriptase Polymerase Chain Reaction; Succinates; Virus Integration; Virus Replication

2003
L-chicoric acid inhibits human immunodeficiency virus type 1 integration in vivo and is a noncompetitive but reversible inhibitor of HIV-1 integrase in vitro.
    Virology, 2004, Sep-01, Volume: 326, Issue:2

    Topics: Acetoacetates; Binding Sites; Caffeic Acids; Cell Line, Tumor; Dose-Response Relationship, Drug; Echinacea; HIV Integrase; HIV Integrase Inhibitors; HIV-1; Humans; Kinetics; Mutation; Polymerase Chain Reaction; Pyrroles; Succinates; Virus Integration

2004
Diketoacid HIV-1 integrase inhibitors: An ab initio study.
    The journal of physical chemistry. A, 2005, Jun-16, Volume: 109, Issue:23

    Topics: Acetoacetates; Algorithms; HIV Integrase Inhibitors; Indoles; Molecular Structure; Pyrroles; Quantum Theory; Tetrazoles

2005
Modeling, analysis, and validation of a novel HIV integrase structure provide insights into the binding modes of potent integrase inhibitors.
    Journal of molecular biology, 2008, Jul-11, Volume: 380, Issue:3

    Topics: Acetoacetates; Binding Sites; Crystallography, X-Ray; DNA, Viral; Furans; HIV Integrase; HIV Integrase Inhibitors; HIV-1; Hydrophobic and Hydrophilic Interactions; Magnesium; Models, Chemical; Models, Molecular; Mutation; Naphthyridines; Nucleic Acid Conformation; Protein Binding; Protein Conformation; Protein Structure, Secondary; Protein Structure, Tertiary; Pyrroles; Reproducibility of Results; Triazoles

2008
Induced-fit docking approach provides insight into the binding mode and mechanism of action of HIV-1 integrase inhibitors.
    ChemMedChem, 2009, Volume: 4, Issue:9

    Topics: Acetoacetates; Anti-HIV Agents; Binding Sites; Computer Simulation; Drug Design; Furans; HIV Integrase; HIV Integrase Inhibitors; Humans; Mutation; Naphthyridines; Pyrroles; Pyrrolidinones; Quinolones; Raltegravir Potassium; Triazoles

2009